News Meet Courtney Cambouris our new NGS specialist! PathoQuest is glad to introduce, Courtney Cambouris, Ph.D. Courtney started as a Technical Sales Consultant with Miltenyi Biotec covering Maryland and Delaware academic, biotech, and government accounts. After...
Happy International Women’s Day8th March Return to the news page They are CSO, Account managers, Chief regulatory affairs officer, Technicians, R&D engineers, Study director….and they represent 58% of PathoQuest talented employees. We are proud to support...
News Viral Safety Expert, Audrey Brussel, joins PathoQuest Pour la version en français de ce communiqué de presse : cliquez ici Audrey Brussel brings her industrial expertise to support the development of added-value services for the quality control of biologics...
News PathoQuest Announces Appointment of Laurent Lafferrere as Chief Operating Officer PARIS, FRANCE, April 27, 2020 – PathoQuest,a leading genomic expert in clinical diagnostics and biologics testing applications with innovative next-generation sequencing (NGS)...
Other Transgene chooses PathoQuest innovative NGS-based safety release test for TG4050 phase I clinical trial targeting patients with head-neck and ovarian cancers and for Invir.IO™ a platform for recombinant viral vector manufacturing. Return to the list of...
Press Release PathoQuest CEO Jean-François Brepson discusses “NGS and New Frontiers in Infectious Disease” during new Illumina Genomics podcast In a new Illumina Genomics Podcast (Episode 53), Jean-François Brepson discusses the company’s vision of the impact of NGS...